Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity

Background Oral squamous cell carcinoma (OSCC) is a deadly disease that develops in a multistage process and is often preceded by oral potentially malignant disorders (PMDs), of which many are caused by tobacco usage. It is associated with a shift from an aerobic to anaerobic glycolytic pathway, and...

Full description

Bibliographic Details
Main Authors: Rashmi Kademadkal Javaraiah, Chaya Manoranjini David, J. Namitha, Ritu Tiwari, Prabhavati Benakanal
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-06-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721174
id doaj-4963216fc62649d487cae59ba9c634fa
record_format Article
spelling doaj-4963216fc62649d487cae59ba9c634fa2020-12-14T23:52:28ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-43062020-06-0190209309810.1055/s-0040-1721174Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral CavityRashmi Kademadkal Javaraiah0Chaya Manoranjini David1J. Namitha2Ritu Tiwari3Prabhavati Benakanal4Department of Dentistry, Kanva Sri Sai Hospital, Bengaluru, Karnataka, IndiaDepartment of Oral Medicine and Maxillofacial Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, IndiaDepartment of Oral Medicine and Maxillofacial Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, IndiaDepartment of Oral Medicine and Maxillofacial Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, IndiaDepartment of Oral Medicine and Maxillofacial Radiology, Sharavathi Dental College, Shimoga, Karnataka, IndiaBackground Oral squamous cell carcinoma (OSCC) is a deadly disease that develops in a multistage process and is often preceded by oral potentially malignant disorders (PMDs), of which many are caused by tobacco usage. It is associated with a shift from an aerobic to anaerobic glycolytic pathway, and hence an increase in lactate dehydrogenase (LDH) levels is seen. The objective of this study was to estimate and correlate the level of salivary LDH in healthy individuals with tobacco users (with or without PMDs). Methods A total of 78 patients were selected from the Department of Oral Medicine and Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India, and were divided into three groups of 26 patients each, namely controls, tobacco users without PMD, and tobacco users with PMD. A total of 1 mL of unstimulated saliva was collected from each patient using the spit method. Sample was subjected to centrifugation at 2,500 rpm, and salivary LDH was quantified by a standard kit (LDH-P kit, DIALAB, Neudorf, Austria) using an autoanalyzer. Results There was a statistically significant (p < 0.001) gradual increase in the level of LDH in controls (267 ± 27.64 U/L), tobacco users without PMD (391 ± 80.53 U/L), and tobacco users with PMD (706.1 ± 199 U/L). Increase in the LDH level was also noted with increased duration and frequency of the habit. Conclusion LDH can potentially be used as a promising biomarker in the very early stages of progression toward oral cancer caused by tobacco use.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721174lactate dehydrogenaseoral cancerprognosissalivatobacco
collection DOAJ
language English
format Article
sources DOAJ
author Rashmi Kademadkal Javaraiah
Chaya Manoranjini David
J. Namitha
Ritu Tiwari
Prabhavati Benakanal
spellingShingle Rashmi Kademadkal Javaraiah
Chaya Manoranjini David
J. Namitha
Ritu Tiwari
Prabhavati Benakanal
Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity
South Asian Journal of Cancer
lactate dehydrogenase
oral cancer
prognosis
saliva
tobacco
author_facet Rashmi Kademadkal Javaraiah
Chaya Manoranjini David
J. Namitha
Ritu Tiwari
Prabhavati Benakanal
author_sort Rashmi Kademadkal Javaraiah
title Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity
title_short Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity
title_full Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity
title_fullStr Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity
title_full_unstemmed Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity
title_sort evaluation of salivary lactate dehydrogenase as a prognostic biomarker in tobacco users with and without potentially malignant disorders of the oral cavity
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
series South Asian Journal of Cancer
issn 2278-330X
2278-4306
publishDate 2020-06-01
description Background Oral squamous cell carcinoma (OSCC) is a deadly disease that develops in a multistage process and is often preceded by oral potentially malignant disorders (PMDs), of which many are caused by tobacco usage. It is associated with a shift from an aerobic to anaerobic glycolytic pathway, and hence an increase in lactate dehydrogenase (LDH) levels is seen. The objective of this study was to estimate and correlate the level of salivary LDH in healthy individuals with tobacco users (with or without PMDs). Methods A total of 78 patients were selected from the Department of Oral Medicine and Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India, and were divided into three groups of 26 patients each, namely controls, tobacco users without PMD, and tobacco users with PMD. A total of 1 mL of unstimulated saliva was collected from each patient using the spit method. Sample was subjected to centrifugation at 2,500 rpm, and salivary LDH was quantified by a standard kit (LDH-P kit, DIALAB, Neudorf, Austria) using an autoanalyzer. Results There was a statistically significant (p < 0.001) gradual increase in the level of LDH in controls (267 ± 27.64 U/L), tobacco users without PMD (391 ± 80.53 U/L), and tobacco users with PMD (706.1 ± 199 U/L). Increase in the LDH level was also noted with increased duration and frequency of the habit. Conclusion LDH can potentially be used as a promising biomarker in the very early stages of progression toward oral cancer caused by tobacco use.
topic lactate dehydrogenase
oral cancer
prognosis
saliva
tobacco
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721174
work_keys_str_mv AT rashmikademadkaljavaraiah evaluationofsalivarylactatedehydrogenaseasaprognosticbiomarkerintobaccouserswithandwithoutpotentiallymalignantdisordersoftheoralcavity
AT chayamanoranjinidavid evaluationofsalivarylactatedehydrogenaseasaprognosticbiomarkerintobaccouserswithandwithoutpotentiallymalignantdisordersoftheoralcavity
AT jnamitha evaluationofsalivarylactatedehydrogenaseasaprognosticbiomarkerintobaccouserswithandwithoutpotentiallymalignantdisordersoftheoralcavity
AT ritutiwari evaluationofsalivarylactatedehydrogenaseasaprognosticbiomarkerintobaccouserswithandwithoutpotentiallymalignantdisordersoftheoralcavity
AT prabhavatibenakanal evaluationofsalivarylactatedehydrogenaseasaprognosticbiomarkerintobaccouserswithandwithoutpotentiallymalignantdisordersoftheoralcavity
_version_ 1724383118349041664